Innovative Non-Viral Manufacturing in CAR-T Therapies

This chapter explores groundbreaking manufacturing processes for CAR-T therapies, focusing on a non-viral method that improves efficiency and reduces costs. It also discusses the role of automation and AI in production, alongside collaborations with academic institutions and the company's vision for future growth in the pharmaceutical industry.